Scarica l'app Stockscreener
12.30
1.23%
0.15
Dopo l'orario di chiusura:
12.39
0.09
+0.73%
Precedente Chiudi:
$12.15
Aprire:
$12.16
Volume 24 ore:
784.01K
Relative Volume:
3.01
Capitalizzazione di mercato:
$150.74M
Reddito:
$1.54M
Utile/perdita netta:
$-38.70M
Rapporto P/E:
-2.6338
EPS:
-4.67
Flusso di cassa netto:
$-36.86M
1 W Prestazione:
-27.69%
1M Prestazione:
-17.06%
6M Prestazione:
+57.89%
1 anno Prestazione:
-27.30%
Intervallo 1D:
$11.64
$12.51
Intervallo di 1 settimana:
$11.59
$18.11
Portata 52W:
$4.64
$20.77
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Nome
Corbus Pharmaceuticals Holdings Inc
Settore
Industria
Telefono
617-963-0103
Indirizzo
500 RIVER RIDGE DRIVE, NORWOOD, MA
Confronta CRBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
12.30 | 148.90M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Ripresa | B. Riley Securities | Buy |
| 2025-02-28 | Iniziato | William Blair | Outperform |
| 2024-12-02 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Iniziato | Wedbush | Outperform |
| 2024-07-22 | Ripresa | H.C. Wainwright | Buy |
| 2024-06-26 | Iniziato | B. Riley Securities | Buy |
| 2024-06-03 | Reiterato | Oppenheimer | Outperform |
| 2024-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-08 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-09-08 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-07-07 | Iniziato | ROTH Capital | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-03-26 | Iniziato | Nomura | Buy |
| 2019-04-05 | Iniziato | Jefferies | Buy |
| 2019-03-20 | Iniziato | Oppenheimer | Outperform |
| 2019-01-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-12-26 | Iniziato | H.C. Wainwright | Buy |
| 2018-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-10-24 | Iniziato | B. Riley FBR | Buy |
| 2018-01-19 | Iniziato | Raymond James | Outperform |
| 2017-12-14 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-11-08 | Reiterato | Noble Financial | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-03-30 | Reiterato | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Reiterato | JMP Securities | Mkt Outperform |
| 2016-11-11 | Reiterato | Noble Financial | Buy |
Mostra tutto
Corbus Pharmaceuticals Holdings Inc Borsa (CRBP) Ultime notizie
Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.71 a shareEarnings Preview - TradingView
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidateMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
Corbus Pharmaceuticals Announces $70.5M Public Offering - TipRanks
Is it time to cut losses on Corbus Pharmaceuticals Holdings Inc.Weekly Volume Report & Step-by-Step Swing Trade Plans - newser.com
Form 424B5 Corbus Pharmaceuticals - StreetInsider
Is Corbus Pharmaceuticals Holdings Inc. stock a contrarian buyPortfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Published on: 2025-11-03 05:13:38 - newser.com
Published on: 2025-11-03 05:07:17 - newser.com
Quantitative breakdown of Corbus Pharmaceuticals Holdings Inc. recent move2025 Top Gainers & High Yield Stock Recommendations - newser.com
Will breakout in Corbus Pharmaceuticals Holdings Inc. lead to full recoveryJuly 2025 Final Week & Pattern Based Trade Signal System - newser.com
AlphaQuest LLC Has $218,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. $CRBP - MarketBeat
How institutional buying supports Corbus Pharmaceuticals Holdings Inc. stockEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock remain on Wall Street radarMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Short interest data insights for Corbus Pharmaceuticals Holdings Inc.Earnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com
Understanding Corbus Pharmaceuticals Holdings Inc.’s price movementJuly 2025 Spike Watch & Safe Entry Point Identification - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock reach $100 price targetIPO Watch & Low Drawdown Investment Strategies - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsTrade Ideas & Stepwise Trade Signal Implementation - newser.com
Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. losses2025 Support & Resistance & Stock Market Timing Techniques - newser.com
How to build a dashboard for Corbus Pharmaceuticals Holdings Inc. stockOil Prices & Growth Focused Stock Reports - newser.com
Corbus Pharmaceuticals slumps 17%, prices $75M at $13 per share - MSN
Published on: 2025-11-02 11:47:57 - newser.com
Published on: 2025-11-02 07:07:31 - newser.com
Comparing Corbus Pharmaceuticals Holdings Inc. in custom built stock radarsMarket Growth Report & Reliable Entry Point Trade Alerts - newser.com
Published on: 2025-11-01 11:30:29 - newser.com
Published on: 2025-11-01 08:40:29 - newser.com
Corbus Pharmaceuticals provides preliminary Q3 cash estimate in SEC filing By Investing.com - Investing.com Australia
Published on: 2025-11-01 04:04:11 - newser.com
Corbus prices $75 million public offering of common stock By Investing.com - Investing.com Philippines
Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP) - Seeking Alpha
Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com - Investing.com UK
Corbus Pharmaceuticals stock plunges after $75 million public offering - Investing.com
Corbus Pharmaceuticals announces common stock offering By Investing.com - Investing.com Australia
Corbus Pharmaceuticals (NASDAQ:CRBP) Share Price Passes Above 50-Day Moving AverageShould You Sell? - MarketBeat
Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Corbus Pharmaceuticals (CRBP) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Published on: 2025-10-31 05:15:03 - newser.com
Published on: 2025-10-31 05:14:27 - newser.com
Corbus Pharmaceuticals Prices $75 Million Offering; Shares Down Pre-Bell - MarketScreener
Corbus prices $75 million public offering of common stock - Investing.com
How Corbus Pharmaceuticals Holdings Inc. (3371) stock compares with market leaders2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Corbus Pharmaceuticals Announces Pricing of Public Offering - The Manila Times
Corbus Pharmaceuticals announces pricing of public offering at $13.00 per share - MarketScreener
Corbus Pharma (Nasdaq: CRBP) prices $75M offering with pre-funded warrants, 30-day option - Stock Titan
Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cohen Yuval | Chief Executive Officer |
Oct 27 '25 |
Option Exercise |
4.26 |
8,973 |
38,225 |
147,160 |
| Cohen Yuval | Chief Executive Officer |
Oct 24 '25 |
Sale |
17.01 |
18,660 |
317,407 |
138,187 |
| Cohen Yuval | Chief Executive Officer |
Oct 27 '25 |
Sale |
17.14 |
8,973 |
153,797 |
138,187 |
| Moran Sean F. | Chief Financial Officer |
Oct 24 '25 |
Option Exercise |
4.26 |
12,981 |
55,299 |
86,294 |
| Moran Sean F. | Chief Financial Officer |
Oct 24 '25 |
Sale |
17.02 |
12,981 |
220,937 |
73,313 |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):